← Browse by Condition
Medical Condition
neoadjuvant therapy
Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2
NCT05406999 Phase 2
Recruiting
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Enrollment
900 pts
Location
China
Sponsor
The Affiliated Nanjing Drum To...
NCT06802666 Phase 2
Recruiting
Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Enrollment
45 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
NCT07388771
Recruiting
Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC）
Enrollment
500 pts
Location
China
Sponsor
Qian Chu
NCT06613165
Recruiting
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
Enrollment
100 pts
Location
China
Sponsor
Xijing Hospital
NCT07389629 Phase 2
Recruiting
Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Enrollment
25 pts
Location
China
Sponsor
Sun Yat-sen University